IRM Energy Limited (IRMENERGY)
Outcome of Board Meeting
Q1FY27 results (unaudited):
Standalone:
Revenue 3.55bn +24% y-y (2.85bn)
EBITDA 0.67bn (derived) EBITDA margin 21.0%
PAT 0.34bn +140% y-y (0.14bn)
Consolidated:
Revenue 3.55bn +24% y-y (2.85bn)
EBITDA 0.67bn (derived) EBITDA margin 21.0%
PAT 0.34bn +143% y-y (0.14bn)
FY26 results (audited):
Standalone:
Revenue 11.6bn +8% y-y (10.7bn)
EBITDA omitted (insufficient data for EBITDA derivation)
PAT 0.57bn +9% y-y (0.53bn)
Consolidated:
Revenue 11.6bn +8% y-y (10.7bn)
EBITDA omitted (insufficient data for EBITDA derivation)
PAT 0.53bn +9% y-y (0.53bn)
Dividend: Rs 1.50/share (record date September 11, 2026)
Commentary: Board approved extension of IPO proceeds utilization timeline to March 31, 2028; project implementation progressing systematically.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 IRMENERGY — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add IRMENERGY to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on IRM Energy Limited
Important.
The summary above is generated automatically from IRM Energy Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.